|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Jan 1, 2025
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CURRENT ASSETS: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Unbilled | ||||||||||||||||||||
| Total accounts receivable, net | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Subscription receivable | ||||||||||||||||||||
| TOTAL CURRENT ASSETS | ||||||||||||||||||||
| Fixed assets, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Right of use asset | ||||||||||||||||||||
| Notes receivable, net of discount and allowance | ||||||||||||||||||||
| Convertible notes receivable, at fair value | ||||||||||||||||||||
| Investment in Evofem | ||||||||||||||||||||
| Deposit on acquisition | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| CURRENT LIABILITIES: | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Mandatorily Redeemable Preferred Stock (2,263 and 1,178 shares) | ||||||||||||||||||||
| Mandatorily Redeemable, Preferred Stock | ||||||||||||||||||||
| Series A-1 Preferred Stock | ||||||||||||||||||||
| Series C-1 Preferred Stock | ||||||||||||||||||||
| Notes payable, related party | ||||||||||||||||||||
| Notes payable, net of discount | ||||||||||||||||||||
| Financing on fixed assets | ||||||||||||||||||||
| Deferred rent | ||||||||||||||||||||
| Operating lease liability, current | ||||||||||||||||||||
| Settlement liability | ||||||||||||||||||||
| Advance on private placement | ||||||||||||||||||||
| TOTAL CURRENT LIABILITIES | ||||||||||||||||||||
| Settlement liability | ||||||||||||||||||||
| Operating lease liability, long term | ||||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| Preferred stock, value | ||||||||||||||||||||
| Series C-1 Preferred Stock | ||||||||||||||||||||
| Series A-1 Convertible Preferred Stock | ||||||||||||||||||||
| Series A-2 Preferred Stock | ||||||||||||||||||||
| Series B-1 Convertible Preferred Stock | ||||||||||||||||||||
| Series B-2 Convertible Preferred Stock | ||||||||||||||||||||
| Series D-1 Preferred Stock ]Member] | ||||||||||||||||||||
| Total preferred stock, value | ||||||||||||||||||||
| Common stock, $0.001 par value, 1,000,000,000 and 100,000,000 shares authorized, 38,631 and 15,297 shares issued and 38,630 and 15,296 shares outstanding, respectively | ||||||||||||||||||||
| Treasury stock, 1 and 1 shares, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| TOTAL ADITXT, INC. STOCKHOLDERS’ EQUITY (DEFICIT) | ||||||||||||||||||||
| NON-CONTROLLING INTEREST | ||||||||||||||||||||
| TOTAL STOCKHOLDERS’ EQUITY (DEFICIT) | ||||||||||||||||||||
| TOTAL LIABILITIES, MEZZANINE EQUITY, AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||||||||||||||||||||
Loading...
